LOGO
LOGO

breaking news

  • Real Brokerage To Acquire RE/MAX, LLC For Around $880 Mln To Create Real REMAX Group April 27, 2026 10:12 ET

    The Real Brokerage Inc. (REAX), a technology-powered real estate brokerage, and RE/MAX Holdings, Inc. (RMAX), a real estate franchisor on Monday announced that they have entered into a definitive agreement where Real Brokerage will acquire RE/MAX, LLC or REMAX, a unit of RE/MAX Holdings, to form a new...

  • Verizon Stock Gains On Higher Q1 Results, Raised FY26 Outlook April 27, 2026 09:53 ET

    Shares of Verizon Communications Inc. were gaining around 3 percent in the early morning trading on the NYSE after the telecom major on Monday lifted fiscal 2026 adjusted earnings outlook after reporting higher profit and revenues for its first quarter. The company said it achieved highest quarterly adjusted EBITDA in company history, and delivered its first positive first-quarter postpaid phone..

  • Adial Pharmaceuticals Applies For FDA Priority Voucher Program For AD04 April 27, 2026 09:16 ET

    Adial Pharmaceuticals, Inc. (ADIL) on Monday said it has submitted its AD04 application for consideration under the U.S. Food and Drug Administration Commissioner's National Priority Voucher Pilot Program (CNPV). The program allows companies to receive an expedited review of a drug application, including...

  • Shell To Buy Canada's ARC Resources In $13.6 Bln Cash, Stock Deal April 27, 2026 09:12 ET

    Oil and gas major Shell Plc (SHEL, SHEL.L) Monday announced that it has entered into a definitive agreement to acquire Canadian energy company ARC Resources Ltd. (AETUF, ARX.TO) in cash and stock deal with equity value of around $13.6 billion. Under the deal terms, ARC shareholders will receive C$8.20...

  • Mirum Pharmaceuticals Reports Positive Phase 2b Results For HDV Therapy April 27, 2026 09:00 ET

    Mirum Pharmaceuticals Inc. (MIRM) on Monday said the primary endpoint was met in the Phase 2b portion of its AZURE-1 study evaluating brelovitug for the treatment of chronic hepatitis delta virus (HDV). At Week 24, brelovitug showed strong antiviral activity, with 100% of patients in the 300 mg weekly...

  • CorMedix Announces Positive Data From Phase 3 REZZAYO Study April 27, 2026 08:55 ET

    CorMedix Inc. (CRMD), Monday announced positive Phase III topline results from the global ReSPECT clinical trial, evaluating REZZAYO for prophylaxis of invasive fungal diseases in adult patients undergoing allogeneic hematopoietic stem cell transplantation. The multicenter, randomized, double-blind...

  • U.S. Stocks May Show A Lack Of Direction In Early Trading April 27, 2026 08:50 ET

    Following the strength seen during last Friday's session, stocks may show a lack of direction in early trading on Monday. The major index futures are currently pointing to a roughly flat open for the markets, with the S&P 500 futures down by less than a tenth of a percent. Traders may be reluctant...

  • Jazz Pharmaceuticals Gets FDA Priority Review For Ziihera In Gastric Cancers April 27, 2026 08:44 ET

    Jazz Pharmaceuticals plc (JAZZ) on Monday said that the U.S. Food and Drug Administration (FDA) has granted priority review to its supplemental Biologics License Application for Ziihera for the first-line treatment of adults with HER2-positive gastric, gastroesophageal junction (GEJ), or gastroesophageal...

  • AbbVie Seeks FDA Nod For SKYRIZI Subcutaneous Induction In Crohn's Disease April 27, 2026 08:32 ET

    AbbVie Inc. (ABBV) on Monday said it has submitted an application to the U.S. Food and Drug Administration seeking approval for a subcutaneous induction regimen of SKYRIZI for adults with moderately to severely active Crohn's disease. The filing is backed by positive Phase 3 AFFIRM study results,...

  • Thermo Fisher To Sell Microbiology Business To Astorg April 27, 2026 08:16 ET

    Thermo Fisher Scientific Inc. (TMO), on Monday, announced that it has signed a definitive agreement to sell its microbiology business to Astorg. The transaction is approximately $1.075 billion, consisting of cash and a $50 million seller note. The deal is expected to close in the second half of...

  • Alterity Therapeutics Gets Positive FDA Feedback On ATH434 Phase 3 Study April 27, 2026 08:16 ET

    Alterity Therapeutics Limited (ATHE) on Monday said it received positive feedback from the U.S. Food and Drug Administration following a Type C meeting regarding its planned Phase 3 program for ATH434 in Multiple System Atrophy (MSA). MSA is a rare neurodegenerative disease with no approved disease-modifying...

  • United Airlines CEO Issues Statement Regarding Potential Merger April 27, 2026 08:05 ET

    United Airlines (UAL) issued a statement from CEO Scott Kirby regarding potential merger between United Airlines and American Airlines. He said American's public comments make it clear that a merger like this is off the table for the foreseeable future. "I approached American about exploring a combination....

  • Martin Marietta Materials Appoints Chris Samborski As COO April 27, 2026 07:36 ET

    Martin Marietta Materials, Inc.(MLM), a supplier of aggregates and other building materials, said on Monday that it has appointed Chris Samborski as chief operating officer with effect from May 1. Most recently, Samborski has served as the president of Martin Marietta's West and Specialties Divisions....

  • Verizon Raises FY26 Adj. EPS Guidance April 27, 2026 07:34 ET

    Verizon Communications (VZ) said, for fiscal 2026, the company now expects adjusted EPS of $4.95 to $4.99, or year-over-year growth of 5.0 to 6.0 percent. Previously, the company expected adjusted EPS of $4.90 to $4.95. Total retail postpaid phone net additions are now expected to be in the top half...

  • HBT Financial Earnings Slid In Q1 April 27, 2026 07:33 ET

    HBT Financial, Inc. (HBT), on Monday reported lower net income in the first quarter compared with the previous year despite higher sales. The decline is due to impacts like the CNB acquisition and AOCI movement. For the first quarter, net income declined to $11.20 million from $19.08 million in the...

Global Economics Weekly Update: April 20 – April 24, 2026

April 24, 2026 15:15 ET
Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.